Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Reinventing Brainlab
Herzlinger, Regina E.; Dessain, Vincent; Misztal, KarolCaso HBS-313069-EDirección estratégicaThe management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment.Desde 8,20 €
-
George's T-Shirts
Frey, Sherwood C. Jr.; Pfeifer, Phillip E.Caso DARDEN-QA-0346-EAnálisis de decisionesGeorge Lasiter sells special-events T-shirts and must decide how many to order for an upcoming concert. He has high, medium, and low estimates of both concert attendance and the percentage of attendees who will want a shirt. In addition, he has assessed the relative likelihoods of each estimate. The case can be used to introduce or reinforce the fundamental issues surrounding decision making under uncertainty.Desde 8,20 €
-
Merck & Company: Product KL-798
Frey, Sherwood C. Jr.; Bodily, Samuel E.Caso DARDEN-QA-0582-EAnálisis de decisionesMerck has been approached by a small biotech research firm with the proposal that Merck buy the rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of phase I of the FDA approval process. Pat Harlow, the chief licensing officer, has been leading Merck's investigation team. A meeting is scheduled for tomorrow at which Merck's response to the offer will be drafted.Desde 8,20 €
-
Merck & Company: Product KL-798 (Spanish version)
Frey, Sherwood C. Jr.; Bodily, Samuel E.Caso DARDEN-QA-0910Análisis de decisionesEsta es una traducción al español de la versión del 14 de junio de 2016 del caso UVA-QA-0582. Merck ha sido contactado por una pequeña empresa de investigación en biotecnología con una propuesta para que Merck compre los derechos de un nuevo medicamento que promete tratar la obesidad y reducir el colesterol. El medicamento se encuentra en la mitad de la fase I del proceso de aprobación de la FDA. Pat Harlow, el director de licencias, ha estado al...Desde 8,20 €
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCaso HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Desde 8,20 €
-
Madison House: Riley Carter
Frey, Sherwood C. Jr.; Bass, Lucien; Grant, MaxCaso DARDEN-QA-0803-EAnálisis de decisionesThis two-part negotiation exercise is used in Negotiations electives at both the Darden School of Business and the McIntire School of Commerce. Together the cases provide the background for a scorable, bilateral, multi-issue negotiation in which there are congruent, distributive, and integrative issues. People and Congregations Engaged in Ministry (PACEM) was a nonprofit organization committed to helping homeless adults in the Charlottesville, Vi...Desde 8,20 €
-
PACEM: Kennedy Brooks
Frey, Sherwood C. Jr.; Bass, Lucien; Grant, MaxCaso DARDEN-QA-0802-EAnálisis de decisionesThis two-part negotiation exercise is used in Negotiations electives at both the Darden School of Business and the McIntire School of Commerce. Together, the cases provide the background for a scorable, bilateral, multi-issue negotiation in which there are congruent, distributive, and integrative issues. People and Congregations Engaged in Ministry (PACEM) was a nonprofit organization committed to helping homeless adults in the Charlottesville, V...Desde 8,20 €
-
Poles apart on PZU (C)
Gino, Francesca; Dessain, Vincent; Misztal, Karol; Khayyat, MichaelCaso HBS-912015-EAfter a decade-long dispute with the Polish State Treasury, in October 2009 the Dutch insurer Eureko agreed to exit PZU in exchange for compensation. Who was the biggest beneficiary of the settlement: Eureko, the Treasury, or PZU itself?Desde 5,74 €
-
BASF: Co-Creating Innovation (B)
Rangan, V. Kasturi; Billaud, Emilie; Dessain, VincentCaso HBS-517074-EMarketingSupplement to case 517073.Desde 5,74 €
-
Veolia: Resourcing the World
Ahuja, Gautam; Khanna, Tarun; Maslauskaite, Kristina; Dessain, VincentCaso HBS-717505-EDirección estratégicaA global environmental service provider goes through major changes to offer integrated solutions and reach out to new countries.Desde 8,20 €